![Matej Mikulic](https://cdn.statcdn.com/static/../CMS/contactperson/ERI285_1713877581.png)
Expected short-term capacity constraints among biopharma manufacturers 2022
According to a study in 2022 among biopharmaceutical manufacturers, when asked about production capacity constraints in five years, around 16 percent stated that there will be significant constraints, while over six percent stated that there will even be severe constraints. However, after pessimistic views during the COVID-19 pandemic, the latest trend is more positive. This statistic shows expected short-term production capacity constraints among biopharmaceutical manufacturers from 2020 to 2022.